Table 2.

Antibacterial screening data of the synthesized derivatives (4a, 4b, 6a-6g, 7a-7g)

Minimum inhibitory concentration (MIC, μmol/mL)
Entry	S. enterica	B. subtilis	S. aureus	P. aeruginosa	E. coli
4a	0.0987	0.0987	0.0493	0.0987	0.0987
4b	0.0493	0.0987	0.0493	0.0987	0.0987
6a	0.0291	0.0145	0.0073	0.0291	0.0145
6b	0.0559	0.0279	0.0140	0.0279	0.0279
6c	0.0539	0.0135	0.0269	0.0135	0.0269
6d	0.0246	0.0123	0.0246	0.0123	0.0246
6e	0.0263	0.0132	0.0263	0.0132	0.0263
6f	0.0272	0.0136	0.0136	0.0272	0.0272
6g	0.0282	0.0141	0.0282	0.0141	0.0282
7a	0.0291	0.0145	0.0073	0.0145	0.0582
7b	0.0279	0.0279	0.0070	0.0140	0.0279
7c	0.0539	0.0539	0.0067	0.0135	0.0135
7d	0.0246	0.0246	0.0061	0.0123	0.0492
7e	0.0263	0.0132	0.0066	0.0132	0.0263
7f	0.0544	0.0136	0.0068	0.0136	0.0136
7g	0.0282	0.0564	0.0141	0.0282	0.0282
Ciprofloxacin	0.0094	0.0094	0.0094	0.0094	0.0094